yes that's very likely. see the path for gsk
phase 1 = positive top line results
phase 2 = positive top line results
fda said proceed to phase 3
phase 3 = negative bottom line results
if a great co like gsk failed then how about gale
I have some interesting herceptin statistics from phase 3
remember herceptin was approved in 1998 while fda was still growing up
for example look at piggy meat by product called acthar gel , approved in 1950 by fda without any clinical efficacy trials and $1 piggy meat by product which could be bought at butcher store now sells for $30k by qcor that too for 19 fda indications from farting balding multiple sclerosis infantile spasms nephrotic syndrome ,,, who knows next will be breast cancer too..
but won't happen anymore
fda has grown up
Prepare for the Dump, going to $3 you can buy more at $3 -- GALE HYPE
Will Gale be another pump and dump like CLSN ? so many cancer companies disappeared not only from the exchanges but from the map
Speaking specifically to the two products that you referenced, an EXPAREL is a longer acting bupivacaine product that's used to provide local site relief at the site of the wound. And traditionally bupivacaine has been around as an agent for use in managing postoperative pain for a long time now. And as the case historically and will be in the future EXPAREL will form one part of a multimodal analgesic regime, which will include opioids and likely include acetaminophen and likely include gabapentinoids and a variety of agents to manage pain effectively from a hosts of different pathways.
And certainly, I don't see EXPAREL as being competitive. I think it's adding to be armamentarium for surgeons and anesthesiologists to manage pain effectively as we will do. And our goal is to be that product of choice when they're looking for an opioid to manage that pain particularly because of the patient-controlled analgesia mechanism that we offer.
Look, i admire your opinion. However, look at pran after the news sell off, look at gale, look at any other co, buy the rumor sell the news
c'mon, this won't happen because the person is suffering from pain, and if he keeps one pill under his pocket, it is not enough to make him high, he needs to keep atleast 300 pills in his pocket for one sniff...sniff...sniff......
It was good pump, I sold at $9.80 and made 45K and will buy back again at lows, I will give you the signal when to buy
Wait and see mode
no one is buying
yeah, I heard this from PharmaMan
Pharmaman claimed " Just to remind everybody, QCOR stated they believed a human trial for ALS would be announced in the first half of 2013. A person close to QCOR told me last week it could be sooner rather than later"
and before him beeglebatty said something about confidential Court hearings of QCOR
SEC should look into these individual
the above posted in april 29 2013 by realshortseller
good luck pharmanan ,,, mexicans gonna give you soap in your rear
search under his Id for last one year
classic pump and dump
mr cohen can you explain the drop from $10.16
I understand you will say low volume
5 consecutive days red
bleeding to $8 again
acrx is sitting on support if it goes up then
anyone know what will happen now ?
kitty is fraudster, she was asking people to buy ZLCS pre-split and post split and and this it is worst one. Well after dropping 90% it is up 10% so kitty is all happy.
she is fake. watch out
TSLA musical chair to stop at $118 , market intensive selloff started ....look at VIX shooting higher